Related Experiment Video
Updated: Apr 17, 2026

Generation of Human Brain Organoids for Mitochondrial Disease Modeling
Published on: June 21, 2021
Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization
Xuan Zhang1, Shishi Li1, Wei Yang1
1Institute of Genetics, College of Life Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, China.
Abstract:
Mitochondrial disease is a group of disorders caused by dysfunctional mitochondria, of which the mutation in the mitochondrial DNA is one of the primary factors. However, the molecular pathogenesis of mitochondrial diseases remains poorly understood due to lack of cell models. Patient-specific induced pluripotent stem cells (iPS cells or iPSCs) are originated from individuals suffering different diseases but carrying unchanged disease causing gene. Therefore, patient-specific iPS cells can be used as excellent cell models to elucidate the mechanisms underlying mitochondrial diseases. Here we present a detailed protocol for generating iPS cells from urine cells and fibroblasts for instance, as well as a series of characterizations.
Insights
Patient-derived induced pluripotent stem cells (iPSCs) offer a powerful tool for studying mitochondrial diseases. This protocol details generating iPSCs from urine and fibroblasts to understand disease mechanisms.
Area of Science:
- Biomedical Sciences
- Cell Biology
- Genetics
Background:
- Mitochondrial diseases stem from dysfunctional mitochondria, often due to mitochondrial DNA mutations.
- Understanding the molecular basis of these diseases is hindered by a lack of suitable cell models.
- Patient-specific induced pluripotent stem cells (iPSCs) retain disease-causing genes, making them ideal disease models.
Purpose of the Study:
- To establish a detailed protocol for generating patient-specific iPSCs.
- To utilize these iPSCs for modeling mitochondrial diseases.
- To facilitate the elucidation of mitochondrial disease pathogenesis.
Main Methods:
- Isolation and reprogramming of somatic cells (urine cells and fibroblasts) into iPSCs.
- Comprehensive characterization of generated iPSCs for pluripotency and disease relevance.
- Application of iPSC models for studying mitochondrial dysfunction.
Main Results:
- Successful generation of iPSCs from patient-derived urine cells and fibroblasts.
- Demonstrated pluripotency and genetic stability of the generated iPSCs.
- Established iPSC lines serve as valuable models for investigating mitochondrial disease mechanisms.
Conclusions:
- Patient-specific iPSCs derived from readily accessible somatic cells provide a robust platform for mitochondrial disease research.
- This protocol enables the creation of disease-specific cellular models to advance understanding of mitochondrial pathogenesis.
- The developed iPSC models are crucial for future therapeutic target identification and drug screening for mitochondrial disorders.
More Related Videos
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
06:09Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives
Published on: November 8, 2021
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
iPS Cell Differentiation